Annual Short Term Debt
$3.08 M
+$381.00 K+14.14%
31 December 2023
Summary:
Heron Therapeutics annual short term debt is currently $3.08 million, with the most recent change of +$381.00 thousand (+14.14%) on 31 December 2023. During the last 3 years, it has fallen by -$6.97 million (-69.40%). HRTX annual short term debt is now -89.28% below its all-time high of $28.68 million, reached on 31 December 2017.HRTX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$3.25 M
+$55.00 K+1.72%
30 September 2024
Summary:
Heron Therapeutics quarterly short term debt is currently $3.25 million, with the most recent change of +$55.00 thousand (+1.72%) on 30 September 2024. Over the past year, it has increased by +$250.00 thousand (+8.34%). HRTX quarterly short term debt is now -88.84% below its all-time high of $29.11 million, reached on 30 June 2018.HRTX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HRTX Short Term Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +14.1% | +8.3% |
3 y3 years | -69.4% | -0.1% |
5 y5 years | -32.8% | -54.1% |
HRTX Short Term Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -69.4% | +27.2% | -0.1% | +34.4% |
5 y | 5 years | -69.4% | +27.2% | -69.5% | +34.4% |
alltime | all time | -89.3% | +2975.0% | -88.8% | +3149.0% |
Heron Therapeutics Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $3.25 M(+1.7%) |
June 2024 | - | $3.19 M(+1.8%) |
Mar 2024 | - | $3.14 M(+2.0%) |
Dec 2023 | $3.08 M(+14.1%) | $3.08 M(+2.5%) |
Sept 2023 | - | $3.00 M(+16.2%) |
June 2023 | - | $2.58 M(-6.6%) |
Mar 2023 | - | $2.76 M(+2.5%) |
Dec 2022 | $2.69 M(+11.5%) | $2.69 M(+2.8%) |
Sept 2022 | - | $2.62 M(+2.8%) |
June 2022 | - | $2.55 M(+2.6%) |
Mar 2022 | - | $2.48 M(+2.8%) |
Dec 2021 | $2.42 M(-76.0%) | $2.42 M(-25.7%) |
Sept 2021 | - | $3.25 M(+2.8%) |
June 2021 | - | $3.16 M(-70.3%) |
Mar 2021 | - | $10.64 M(+5.8%) |
Dec 2020 | $10.05 M(+33.1%) | $10.05 M(+5.2%) |
Sept 2020 | - | $9.55 M(+4.9%) |
June 2020 | - | $9.10 M(+4.7%) |
Mar 2020 | - | $8.69 M(+15.1%) |
Dec 2019 | $7.55 M(+65.1%) | $7.55 M(+6.7%) |
Sept 2019 | - | $7.08 M(+4.0%) |
June 2019 | - | $6.80 M(-0.7%) |
Mar 2019 | - | $6.85 M(+49.8%) |
Dec 2018 | $4.57 M(-84.1%) | $4.57 M(+5.4%) |
Sept 2018 | - | $4.34 M(-85.1%) |
June 2018 | - | $29.11 M(+0.8%) |
Mar 2018 | - | $28.89 M(+0.7%) |
Dec 2017 | $28.68 M(+885.4%) | $28.68 M(+724.0%) |
Sept 2017 | - | $3.48 M(+6.0%) |
June 2017 | - | $3.29 M(+6.1%) |
Mar 2017 | - | $3.10 M(+6.4%) |
Dec 2016 | $2.91 M(+31.0%) | $2.91 M(+6.6%) |
Sept 2016 | - | $2.73 M(+6.8%) |
June 2016 | - | $2.56 M(+7.1%) |
Mar 2016 | - | $2.39 M(+7.5%) |
Dec 2015 | $2.22 M(+39.0%) | $2.22 M(+7.8%) |
Sept 2015 | - | $2.06 M(+8.3%) |
June 2015 | - | $1.90 M(+8.8%) |
Mar 2015 | - | $1.75 M(+9.4%) |
Dec 2014 | $1.60 M | $1.60 M(+10.2%) |
Sept 2014 | - | $1.45 M(+11.0%) |
Date | Annual | Quarterly |
---|---|---|
June 2014 | - | $1.31 M(+12.2%) |
Mar 2014 | - | $1.16 M(+13.6%) |
Dec 2013 | $1.02 M(+108.3%) | $1.02 M(+15.4%) |
Sept 2013 | - | $888.00 K(+17.8%) |
June 2013 | - | $754.00 K(+21.2%) |
Mar 2013 | - | $622.00 K(+26.4%) |
Dec 2012 | $492.00 K(+377.7%) | $492.00 K(+377.7%) |
Dec 2011 | $103.00 K(-88.4%) | $103.00 K(-89.2%) |
June 2000 | - | $954.70 K(+3.5%) |
Mar 2000 | - | $922.40 K(+3.5%) |
Dec 1999 | $891.10 K(-71.3%) | $891.10 K(-10.9%) |
Sept 1999 | - | $1.00 M(0.0%) |
June 1999 | - | $1.00 M(-16.7%) |
Mar 1999 | - | $1.20 M(-61.3%) |
Dec 1998 | $3.10 M(+24.0%) | $3.10 M(-16.2%) |
Sept 1998 | - | $3.70 M(-11.9%) |
June 1998 | - | $4.20 M(-8.7%) |
Mar 1998 | - | $4.60 M(+84.0%) |
Dec 1997 | $2.50 M(+66.7%) | $2.50 M(0.0%) |
Sept 1997 | - | $2.50 M(+13.6%) |
June 1997 | - | $2.20 M(+22.2%) |
Mar 1997 | - | $1.80 M(+20.0%) |
Dec 1996 | $1.50 M(+66.7%) | $1.50 M(-44.4%) |
Sept 1996 | - | $2.70 M(+17.4%) |
June 1996 | - | $2.30 M(+53.3%) |
Mar 1996 | - | $1.50 M(+66.7%) |
Dec 1995 | $900.00 K(-59.1%) | $900.00 K(+28.6%) |
Sept 1995 | - | $700.00 K(-66.7%) |
June 1995 | - | $2.10 M(-4.5%) |
Mar 1995 | - | $2.20 M(0.0%) |
Dec 1994 | $2.20 M(+633.3%) | $2.20 M(+633.3%) |
Sept 1994 | - | $300.00 K(0.0%) |
June 1994 | - | $300.00 K(0.0%) |
Mar 1994 | - | $300.00 K(0.0%) |
Dec 1993 | $300.00 K(0.0%) | $300.00 K(0.0%) |
Sept 1993 | - | $300.00 K(0.0%) |
June 1993 | - | $300.00 K(0.0%) |
Mar 1993 | - | $300.00 K(0.0%) |
Dec 1992 | $300.00 K(+200.0%) | $300.00 K(-90.0%) |
Sept 1990 | - | $3.00 M(0.0%) |
June 1990 | - | $3.00 M(+2900.0%) |
Dec 1987 | $100.00 K | $100.00 K |
FAQ
- What is Heron Therapeutics annual short term debt?
- What is the all time high annual short term debt for Heron Therapeutics?
- What is Heron Therapeutics annual short term debt year-on-year change?
- What is Heron Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Heron Therapeutics?
- What is Heron Therapeutics quarterly short term debt year-on-year change?
What is Heron Therapeutics annual short term debt?
The current annual short term debt of HRTX is $3.08 M
What is the all time high annual short term debt for Heron Therapeutics?
Heron Therapeutics all-time high annual short term debt is $28.68 M
What is Heron Therapeutics annual short term debt year-on-year change?
Over the past year, HRTX annual short term debt has changed by +$381.00 K (+14.14%)
What is Heron Therapeutics quarterly short term debt?
The current quarterly short term debt of HRTX is $3.25 M
What is the all time high quarterly short term debt for Heron Therapeutics?
Heron Therapeutics all-time high quarterly short term debt is $29.11 M
What is Heron Therapeutics quarterly short term debt year-on-year change?
Over the past year, HRTX quarterly short term debt has changed by +$250.00 K (+8.34%)